| 2025-12-16 |
详情>>
内部人交易：
Frankel Stanley等共交易2笔
|
| 2025-11-12 |
详情>>
股本变动：
变动后总股本2407.18万股
变动原因 ▼▲
- 原因：
- Common Stock offered 10,815,000 shares by the company
|
| 2025-11-11 |
复牌提示：
2025-11-10 16:55:00 停牌，复牌日期 2025-11-10 17:55:00
|
| 2025-11-03 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-6.14美元,归母净利润-6585.7万美元,同比去年增长-364.36%
|
| 2025-11-03 |
财报披露：
美东时间 2025-11-03 盘前发布财报
|
| 2025-08-07 |
详情>>
业绩披露：
2025年中报每股收益-4.33美元,归母净利润-4408.5万美元,同比去年增长-206.65%
|
| 2025-05-15 |
详情>>
业绩披露：
2025年一季报每股收益-2.21美元,归母净利润-2056.5万美元,同比去年增长-339.46%
|
| 2025-04-15 |
股东大会：
将于2025-05-28召开股东大会
会议内容 ▼▲
- 1.To elect Kevin J. Buehler and Shari Lisa Piré as Class III directors to hold office until the Company’s annual meeting of stockholders to be held in 2028 and until their respective successors have been duly elected and qualified.
2.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2025.
3.Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers (commonly referred to as the “say-on-pay vote”).
4.Approval, on an advisory (non-binding) basis, of the frequency of future say-on-pay votes.
5.Approval of an amendment to our Certificate of Incorporation to reflect changes in Delaware law regarding officer exculpation.
6.To transact such other business as may properly come before the Annual Meeting or any continuation, postponement or adjournment thereof.
|
| 2025-03-26 |
详情>>
业绩披露：
2024年年报每股收益1.05美元,归母净利润716.70万美元,同比去年增长111.69%
|
| 2024-11-04 |
详情>>
业绩披露：
2024年三季报(累计)每股收益3.87美元,归母净利润2491.20万美元,同比去年增长155.32%
|
| 2024-08-01 |
详情>>
业绩披露：
2024年中报每股收益6.87美元,归母净利润4133.70万美元,同比去年增长211.87%
|
| 2024-05-13 |
详情>>
业绩披露：
2024年一季报每股收益1.70美元,归母净利润858.80万美元,同比去年增长134.27%
|
| 2024-04-25 |
股东大会：
将于2024-06-04召开股东大会
会议内容 ▼▲
- 1.To elect Stanley R. Frankel, M.D. and Samuel Wadsworth, Ph.D. as Class II directors to hold office until the Company’s annual meeting of stockholders to be held in 2027 and until their respective successors have been duly elected and qualified.
2.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2024.
3.To approve the amendment and restatement of the Company's 2019 Incentive Award Plan.
4.To approve an adjournment the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal No. 3.
5.To transact such other business as may properly come before the Annual Meeting or any continuation, postponement or adjournment thereof.
|
| 2024-03-27 |
详情>>
业绩披露：
2023年年报每股收益-15.96美元,归母净利润-6131.9万美元,同比去年增长45.07%
|
| 2024-02-14 |
详情>>
拆分方案：
每30.0000合并分成1.0000股
|
| 2023-12-04 |
股东大会：
将于2024-01-18召开股东大会
会议内容 ▼▲
- 1.To approve amendments to our amended and restated certificate of incorporation to effect a reverse stock split of our Common Stock at a ratio ranging from any whole number between 1-for-10 and 1-for-30, as determined by our Board of Directors (the “Board”) in its discretion, subject to the Board’s authority to abandon such amendments;
2.To approve an adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Special Meeting to approve Proposal 1;
3.To transact such other business as may properly come before the Special Meeting or any continuation, postponement or adjournment thereof.
|
| 2023-11-07 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.4美元,归母净利润-4503万美元,同比去年增长45.84%
|
| 2023-08-04 |
详情>>
业绩披露：
2023年中报每股收益-0.33美元,归母净利润-3695.1万美元,同比去年增长37.59%
|
| 2023-03-23 |
股东大会：
将于2023-05-04召开股东大会
会议内容 ▼▲
- 1.To elect Michael Amoroso and Geno Germano as Class I directors to hold office until the Company’s annual meeting of stockholders to be held in 2026 and until their respective successors have been duly elected and qualified;
2.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2023;
3.To transact such other business as may properly come before the Annual Meeting or any continuation, postponement or adjournment thereof.
|
| 2022-03-29 |
股东大会：
将于2022-05-10召开股东大会
会议内容 ▼▲
- 1.to elect Kevin J. Buehler and Shari Lisa Piré as Class III directors to hold office until the Company’s annual meeting of stockholders to be held in 2025 and until their respective successors have been duly elected and qualified;
2.to ratify, in a non-binding vote, the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2022;
3.to transact such other business as may properly come before the Annual Meeting or any continuation, postponement or adjournment thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-12 |
股东大会：
将于2021-05-10召开股东大会
会议内容 ▼▲
- 1.to elect Stanley R. Frankel, M.D. and Derek Jantz, Ph.D. as Class II directors to hold office until the Company’s annual meeting of stockholders to be held in 2024 and until their respective successors have been duly elected and qualified;
2.to ratify, in a non-binding vote, the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2021
3.to transact such other business as may properly come before the Annual Meeting or any continuation, postponement or adjournment thereof.
|
| 2020-03-27 |
股东大会：
将于2020-05-13召开股东大会
会议内容 ▼▲
- 1.to elect Geno Germano, Matthew Kane and Raymond Schinazi, Ph.D. as Class I directors to hold office until the Company’s annual meeting of stockholders to be held in 2023 and until their respective successors have been duly elected and qualified;
2.to ratify, in a non-binding vote, the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2020;
3.to transact such other business as may properly come before the Annual Meeting or any continuation, postponement or adjournment thereof.
|